Format

Send to

Choose Destination
Methods Mol Med. 2003;85:79-86.

Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.

Author information

1
Department of Cell Biology, Basque Country University School of Medicine and Dentistry, Leioa, Spain.
PMID:
12710199
DOI:
10.1385/1-59259-380-1:79
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center